MYRIAD GENETICS, INC. Other Revenue, Net (Deprecated 2018-01-31)
MYRIAD GENETICS, INC. (MYGN) reported Other Revenue, Net (Deprecated 2018-01-31) of $13.80 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Income Statement › Other Income
us-gaap:OtherSalesRevenueNet · last filed 2018-05-09
- MYRIAD GENETICS, INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $13.80M, a 17.95% increase year-over-year.
- MYRIAD GENETICS, INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $14.80M, a 17.46% increase year-over-year.
- MYRIAD GENETICS, INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $11.40M, a 8.06% decline year-over-year.
- MYRIAD GENETICS, INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $12.60M, a 0.79% decline year-over-year.
- MYRIAD GENETICS, INC. other revenue, net (deprecated 2018-01-31) for fiscal 2017 was $49.30M, a 2.49% increase from fiscal 2016.
- MYRIAD GENETICS, INC. other revenue, net (deprecated 2018-01-31) for fiscal 2016 was $48.10M, a 74.28% increase from fiscal 2015.
- MYRIAD GENETICS, INC. other revenue, net (deprecated 2018-01-31) for fiscal 2015 was $27.60M, a 8.00% decline from fiscal 2014.
- MYRIAD GENETICS, INC. other revenue, net (deprecated 2018-01-31) for fiscal 2014 was $30.00M, a 2.60% decline from fiscal 2013.
| Period end | Other Revenue, Net (Deprecated 2018-01-31) 3 month | Other Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Other Revenue, Net (Deprecated 2018-01-31) 6 month | Other Revenue, Net (Deprecated 2018-01-31) 6 month as first filed | Other Revenue, Net (Deprecated 2018-01-31) 9 month | Other Revenue, Net (Deprecated 2018-01-31) 9 month as first filed | Other Revenue, Net (Deprecated 2018-01-31) 12 month | Other Revenue, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $13.80M 10-Q · filed 2018-05-09 | $28.60M derived: sum of 2 quarters · filed 2018-05-09 | $40.10M 10-Q · filed 2018-05-09 | $52.60M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-12-31 | $14.80M 10-Q · filed 2018-02-07 | $26.20M 10-Q · filed 2018-02-07 | $38.80M derived: sum of 3 quarters · filed 2018-02-07 | $50.50M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-09-30 | $11.40M 10-Q · filed 2017-11-08 | $24.00M derived: sum of 2 quarters · filed 2017-11-08 | $35.70M derived: sum of 3 quarters · filed 2018-05-09 | $48.30M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-06-30 | $12.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $24.30M derived: sum of 2 quarters · filed 2018-05-09 | $36.90M derived: sum of 3 quarters · filed 2018-05-09 | $49.30M 10-K · filed 2017-08-09 | ||||
| 2017-03-31 | $11.70M 10-Q · filed 2018-05-09 | $24.30M derived: sum of 2 quarters · filed 2018-05-09 | $36.70M 10-Q · filed 2018-05-09 | $49.40M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2016-12-31 | $12.60M 10-Q · filed 2018-02-07 | $25.00M 10-Q · filed 2018-02-07 | $37.70M derived: sum of 3 quarters · filed 2018-02-07 | $50.80M derived: sum of 4 quarters · filed 2018-02-07 | ||||
| 2016-09-30 | $12.40M 10-Q · filed 2017-11-08 | $25.10M derived: sum of 2 quarters · filed 2017-11-08 | $38.20M derived: sum of 3 quarters · filed 2017-11-08 | $48.90M derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | $12.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $25.80M derived: sum of 2 quarters · filed 2017-08-09 | $36.50M derived: sum of 3 quarters · filed 2017-08-09 | $48.10M 10-K · filed 2017-08-09 | ||||
| 2016-03-31 | $13.10M 10-Q · filed 2017-05-03 | $23.80M derived: sum of 2 quarters · filed 2017-05-03 | $35.40M 10-Q · filed 2017-05-03 | $46.40M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-12-31 | $10.70M 10-Q · filed 2017-02-08 | $22.30M 10-Q · filed 2017-02-08 | $33.30M derived: sum of 3 quarters · filed 2017-08-09 | $40.30M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-09-30 | $11.60M 10-Q · filed 2016-11-02 | $22.60M derived: sum of 2 quarters · filed 2017-08-09 | $29.60M derived: sum of 3 quarters · filed 2017-08-09 | $34.80M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-06-30 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $18.00M derived: sum of 2 quarters · filed 2017-08-09 | $23.20M derived: sum of 3 quarters · filed 2017-08-09 | $27.60M 10-K · filed 2017-08-09 | ||||
| 2015-03-31 | $7.00M 10-Q · filed 2016-05-04 | $7.01M 10-Q · filed 2015-05-06 | $12.20M derived: sum of 2 quarters · filed 2016-05-04 | $16.60M 10-Q · filed 2016-05-04 | $16.58M 10-Q · filed 2015-05-06 | $22.39M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2014-12-31 | $5.20M 10-Q · filed 2016-02-03 | $5.24M 10-Q · filed 2015-02-04 | $9.60M 10-Q · filed 2016-02-03 | $9.57M 10-Q · filed 2015-02-04 | $15.38M derived: sum of 3 quarters · filed 2016-08-10 | $22.12M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2014-09-30 | $4.30M 10-Q · filed 2015-11-04 | $4.33M 10-Q · filed 2014-11-05 | $10.19M derived: sum of 2 quarters · filed 2016-08-10 | $16.92M derived: sum of 3 quarters · filed 2016-08-10 | $24.82M derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2014-06-30 | $5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-10 | $12.62M derived: sum of 2 quarters · filed 2016-08-10 | $20.52M derived: sum of 3 quarters · filed 2016-08-10 | $30.00M 10-K · filed 2016-08-10 | $30.02M 10-K · filed 2014-08-13 | |||
| 2014-03-31 | $6.73M 10-Q · filed 2015-05-06 | $14.63M derived: sum of 2 quarters · filed 2015-05-06 | $24.11M 10-Q · filed 2015-05-06 | $32.17M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-12-31 | $7.90M 10-Q · filed 2015-02-04 | $17.38M 10-Q · filed 2015-02-04 | $25.44M derived: sum of 3 quarters · filed 2015-08-12 | $33.52M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-09-30 | $9.48M 10-Q · filed 2014-11-05 | $17.53M derived: sum of 2 quarters · filed 2015-08-12 | $25.62M derived: sum of 3 quarters · filed 2015-08-12 | $34.11M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-06-30 | $8.05M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | $16.14M derived: sum of 2 quarters · filed 2015-08-12 | $24.63M derived: sum of 3 quarters · filed 2015-08-12 | $30.80M 10-K · filed 2015-08-12 | $30.77M 10-K · filed 2013-08-14 | |||
| 2013-03-31 | $8.09M 10-Q · filed 2014-05-07 | $16.58M derived: sum of 2 quarters · filed 2014-05-07 | $22.75M 10-Q · filed 2014-05-07 | $28.21M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-12-31 | $8.49M 10-Q · filed 2014-02-05 | $14.66M 10-Q · filed 2014-02-05 | $20.12M derived: sum of 3 quarters · filed 2014-08-13 | $26.59M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-09-30 | $6.17M 10-Q · filed 2013-11-12 | $11.63M derived: sum of 2 quarters · filed 2014-08-13 | $18.10M derived: sum of 3 quarters · filed 2014-08-13 | $23.30M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-06-30 | $5.47M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | $11.93M derived: sum of 2 quarters · filed 2014-08-13 | $17.13M derived: sum of 3 quarters · filed 2014-08-13 | $23.61M 10-K · filed 2014-08-13 | ||||
| 2012-03-31 | $6.46M 10-Q · filed 2013-05-08 | $11.67M derived: sum of 2 quarters · filed 2013-05-08 | $18.15M 10-Q · filed 2013-05-08 | |||||
| 2011-12-31 | $5.20M 10-Q · filed 2013-02-06 | $11.68M 10-Q · filed 2013-02-06 | ||||||
| 2011-09-30 | $6.48M 10-Q · filed 2012-11-09 | |||||||
| 2011-06-30 | $2.04M 10-K · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |